View More View Less
  • 1 College of Applied Medical Sciences, King Saud University, Saudi Arabia
  • | 2 KVG Dental College and Hospital, India
  • | 3 Security Force Hospital, Saudi Arabia
  • | 4 Springs Dental Care, UK
  • | 5 College of Dentistry, Prince Sattam Bin Abdulaziz University, Saudi Arabia
  • | 6 Visiting Professor, College of Applied Medical Sciences, King Saud University, Saudi Arabia
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Oral streptococci are the major group of microbes isolated from oral microflora. They represent frequent pathogens of infective endocarditis (IE), and it is assumed that in most of the cases oral streptococci are acquired via mucosa layer of oral cavity. Staphylococcus aureus is also frequently isolated from IE as it accounts for 20%–30% of all cases. Vancomycin has been the most reliable therapeutic agent against infections caused by methicillin-resistant S. aureus (MRSA). The main objective of this study was to examine the occurrence of S. aureus species in dental caries specimens. Antimicrobial susceptibility testing of S. aureus to four antibiotics namely vancomycin, linezolid, teicoplanin, and daptomycin was performed. Detection of vancomycin resistance was conducted using polymerase chain reaction. Among the tested 150 strains, 98 were MRSA and of that 54 were vancomycin sensitive and 27 were resistant. All 98 MRSA strains were positive for mecA and 36 yielded pvl, whereas 13 carried vanA and only 2 were positive for vanB. Majority of the isolates showed sensitivity toward daptomycin and linezolid. Strains of S. aureus exhibiting decreased susceptibility to different antibiotics like vancomycin, daptomycin, and linezolid severely compromise the therapeutic alternatives and require a considerable amount of time, public awareness, and integrative health-care strategies to prevent the emergence of resistance to these compounds.

  • 1.

    Deresinski, S.: Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 40, 562573 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    King, M. D., Humphrey, B. J., Wang, Y. F., Kourbatova, E. V., Ray, S. M., Blumberg, H. M.: Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144, 309317 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Thati, V., Shivannavar, C. T., Gaddad, S. M.: Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res 134, 704 (2011).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Azimian, A., Havaei, S. A., Fazeli, H., Naderi, M., Ghazvini, K., Samiee, S. M., Soleimani, M., Peerayeh, S. N.: Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran. J Clin Microbiol 50, 35813585 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Howden, B. P., Davies, J. K., Johnson, P. D., Stinear, T. P., Grayson, M. L.: Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: Resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 23, 99139 (2010).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Lodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M., Stellrecht, K.: Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 52, 33153320 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Paterson, G. K., Harrison, E. M., Holmes, M. A.: The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends Microbiol 22, 4247 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Lepsanovic, Z., Jeremic, L. P., Lazic, S., Cirkovic, I.: High prevalence and resistance patterns of community-associated methicillin-resistant Staphylococcus aureus in the Pomoravlje Region, Serbia. Acta Microbiol Immunol Hung 63, 8392 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Ohara-Nemoto, Y., Haraga, H., Kimura, S., Nemoto, T. K.: Occurrence of staphylococci in the oral cavities of healthy adults and nasal–oral trafficking of the bacteria. J Med Microbiol 57, 9599 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Cecchi, E., Forno, D., Imazio, M., Migliardi, A., Gnavi, R., Dal Conte, I., Trinchero, R.: New trends in the epidemiological and clinical features of infective endocarditis: Results of a multicenter prospective study. Ital Heart J 5, 249256 (2004).

    • Search Google Scholar
    • Export Citation
  • 11.

    Nakatani, S., Mitsutake, K., Hozumi, T., Yoshikawa, J., Akiyama, M., Yoshida, K., Ishizuka, N., Nakamura, K., Taniguchi, Y., Yoshioka, K., Kawazoe, K., Akaishi, M., Niwa, K., Nakazawa, M., Kitamura, S., Miyatake, K.; Committee on Guideline for Prevention and Management of Infective Endocarditis, Japanese Circulation Society: Current characteristics of infective endocarditis in Japan: An analysis of 848 cases in 2000 and 2001. Circ J 67, 901905 (2003).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Di Filippo, S., Delahaye, F., Semiond, B., Celard, M., Henaine, R., Ninet, J., Sassolas, F., Bozio, A.: Current patterns of infective endocarditis in congenital heart disease. Heart 92, 14901495 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Ikeda, Y., Ohara-Nemoto, Y., Kimura, S., Ishibashi, K., Kikuchi, K.: PCR-based identification of Staphylococcus epidermidis targeting gseA encoding the glutamic-acid-specific protease. Can J Microbiol 50, 493498 (2004).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Yamashita, K., Ohara, M., Kojima, T., Nishimura, R., Ogawa, T., Hino, T., Okada, M., Toratani, S., Kamata, N., Sugai, M., Sugiyama, M.: Prevalence of drug-resistant opportunistic microorganisms in oral cavity after treatment for oral cancer. J Oral Sci 55, 145155 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Appelbaum, P. C.: The emergence of vancomycin‐intermediate and vancomycin‐resistant Staphylococcus aureus. Clin Microbiol Infect 12, 1623 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Hiramatsu, K.: Vancomycin-resistant Staphylococcus aureus: A new model of antibiotic resistance. Lancet Infect Dis 1, 147155 (2001).

  • 17.

    Moellering, R. C.: Vancomycin-resistant enterococci. Clin Infect Dis 26, 11961199 (1998).

  • 18.

    Hoen, B., Alla, F., Selton-Suty, C., Béguinot, I., Bouvet, A., Briançon, S., Casalta, J. P., Danchin, N., Delahaye, F., Etienne, J., Le Moing, V., Leport, C., Mainardi, J. L., Ruimy, R., Vandenesch, F.: Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group: Changing profile of infective endocarditis: Results of a 1-year survey in France. JAMA 288, 7581 (2002).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Niwa, K., Nakazawa, M., Tateno, S., Yoshinaga, M., Terai, M.: Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart 91, 795800 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Anguera, I., Del Río, A., Miró, J. M., Matínez-Lacasa, X., Marco, F., Gumá, J. R., Quaglio, G., Claramonte, X., Moreno, A., Mestres, C. A., Mauri, E., Azqueta, M., Benito, N., García-de la María, C., Almela, M., Jiménez-Expósito, M. J., Sued, O., De Lazzari, E., Gatell, J. M.: Hospital Clinic Endocarditis Study Group: Staphylococcus lugdunensis infective endocarditis: Description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart 91, e10 (2005).

    • Crossref
    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
submission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2021 18 0 0
Jul 2021 21 0 0
Aug 2021 22 0 0
Sep 2021 21 1 2
Oct 2021 14 0 0
Nov 2021 14 0 0
Dec 2021 16 0 0